Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors

Clinical trial NCT03832569 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03832569
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Solid Tumors Identified by NGS, PCR or IHC

Start date: 2019-02-20
Primary completion: 2027-02-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.